Antihemophilic Factor (Recombinant) PEGylated

FDA Drug Profile — ADYNOVATE

Antihemophilic Factor (Recombinant) PEGylated is listed in the FDA National Drug Code directory with 14 NDC codes, marketed under brand name including ADYNOVATE. Available dosage form: kit.

Drug Details

Generic Name
Antihemophilic Factor (Recombinant) PEGylated
Brand Names
ADYNOVATE
Application Number
BLA125566
Sponsor
Takeda Pharmaceuticals Amercia, Inc.
NDC Codes
14
Dosage Forms
KIT
Routes
N/A
Active Ingredients
N/A